Showing results (31-40 of 196) with videos related to

Sort By:
Pageof 20
Bailliere'S Clinical Haematology|September 1, 1996
Hodgkin's disease. Future treatment strategies: fact or fiction?R Schnell, S Barth, V Diehl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Current clinical trials in Hodgkin's diseaseK Reuss, A Engert, H Tesch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Development of immunotoxins for potential clinical use in Hodgkin's diseaseS Barth, R Schnell, V Diehl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
New drugs in the treatment of Hodgkin's diseaseP Borchmann, R Schnell, V Diehl, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 1, 1997
Idarubicin: a brief overview on pharmacology and clinical useP Borchmann, K Hübel, R Schnell, et al.
The Cochrane Database of Systematic Reviews|July 22, 2004
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphomaJ Bohlius, M Reiser, G Schwarzer, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Non-Hodgkin's Lymphoma: A Review of Immunotherapeutic Approaches to TreatmentR Schnell, S Barth, V Diehl, et al.
The Cochrane Database of Systematic Reviews|January 10, 2003
Granulopoiesis-stimulating factors in the prevention for adverse effects in the therapeutic treatment of malignant lymphomaJ Bohlius, M Reiser, G Schwarzer, et al.
Cancer Genetics and Cytogenetics|June 1, 1987
Translocation (6;9)(p23;q34) in smoldering leukemia and acute nonlymphocytic leukemiaC Fonatsch, B Stollmann, J Holldack, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2002
Current strategies of antibody-based treatment in Hodgkin's diseaseR Schnell, P Borchmann, H Schulz, et al.
Pageof 20